Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2005
09/15/2005US20050202068 Fiber sheets to fit on a finger; cleansing and/or treating the skin, hair
09/15/2005US20050202067 Matrix structure and hybrid matrix system for inducing a neofacia, their use and method for generating a neofacia
09/15/2005US20050202053 Taste masking complex of antihistamine and alginate
09/15/2005US20050202052 Flavored medicaments to deter or attract and kill microorganisms
09/15/2005US20050202051 Ejecting pharmaceutical components from a reservoir onto a solid, orally ingestible pharmaceutical receiving medium and a vehicle that evaporates from the receiving medium
09/15/2005US20050202050 Single tank process for preparing tannate liquid and semi-solid dosage forms
09/15/2005US20050201980 Method for short-term and long-term drug dosimetry
09/15/2005US20050201974 Bioadhesive polymers with catechol functionality
09/15/2005US20050201973 Therapeutic supramolecules
09/15/2005US20050201971 Advertisement method
09/15/2005US20050201951 Inhalation of alpha one-antitrypsin (AAT); emphysema; cigarettes and kits comprising AAT
09/15/2005US20050201950 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
09/15/2005US20050201949 Pharmaceutical formulations
09/15/2005US20050201948 Granules of sugar such as glucose, lactose, fructose, mannitol or sucrose; dry powder inhalers
09/15/2005US20050201947 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
09/15/2005US20050201946 Intranasal influenza virus vaccine
09/15/2005US20050201940 Diagnostics and radiotherapy; magnetic resonance imaging (MRI); treatment of a tumor
09/15/2005US20050201888 Sterilization process
09/15/2005DE102004010153A1 Perorale Vitamin E-enthaltende Zubereitungen Oral vitamin E-containing preparations
09/15/2005CA2558416A1 Use of lipid conjugates in the treatment of disease
09/15/2005CA2558263A1 Nanocell drug delivery system
09/15/2005CA2558200A1 Compositions for repairing bone and methods for preparing and using such compositions
09/15/2005CA2558198A1 Crystalline composition containing escitalopram oxalate
09/15/2005CA2558027A1 Polymeric drug delivery system for hydrophobic drugs
09/15/2005CA2557983A1 Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, dna vaccination and administration of gene based drugs
09/15/2005CA2557968A1 Method and composition for burned skin
09/15/2005CA2557876A1 Powdered compositions of sensitive active materials in an at least partially amorphous state
09/15/2005CA2557634A1 Stable capsule preparation
09/15/2005CA2557553A1 Pharmaceutical ocular preparations suitable for the treatment of the ocular surface and related disorders/diseases
09/15/2005CA2557435A1 Stable pharmaceutical solution formulations for pressurized metered dose inhalers
09/15/2005CA2557161A1 Pharmaceutical composition comprising pimobendan
09/15/2005CA2556939A1 Embolic particles
09/15/2005CA2555974A1 Pharmaceutical composition for topical use in form of xerogels or films and methods for production
09/15/2005CA2555921A1 Therapeutic calcium phosphate particles and methods of making and using same
09/15/2005CA2530514A1 Cell therapy formulation method and composition
09/14/2005EP1574578A1 Monomeric protein of the TGF-beta family
09/14/2005EP1574577A2 Growth differentiation factor-11
09/14/2005EP1574534A1 Polymer carriers and process
09/14/2005EP1574222A1 Sterilization process
09/14/2005EP1574221A1 Stable injectable diclofenac compositions
09/14/2005EP1574220A1 Light-blocking agent and film-forming composition
09/14/2005EP1574215A1 Solid drug for oral use
09/14/2005EP1574214A1 Pharmaceutical composition comprising fenofibrate and process for its preparation
09/14/2005EP1574210A2 Microemulsions with adsorbed macromolecules and microparticles
09/14/2005EP1574209A1 Device and method for treating ophthalmic diseases
09/14/2005EP1574207A1 Cosmetic use of viscous compositions containing carbon dioxide
09/14/2005EP1574202A2 Hair mousse with long-lasting effect
09/14/2005EP1574165A2 Fiber optic probe placement guide
09/14/2005EP1573003A2 Method for producing transgenic animals using oral gene therapy
09/14/2005EP1572930A2 Albumin-fused kunitz domain peptides
09/14/2005EP1572915A2 Preservation of bioactive materials by spray drying
09/14/2005EP1572897A2 Ordered biological nanostructures formed from chaperonin polypeptides
09/14/2005EP1572728A2 Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
09/14/2005EP1572622A1 Levalbuterol salt
09/14/2005EP1572344A1 Pellets and method for production thereof
09/14/2005EP1572341A2 Hazard-free microencapsulation for structurally delicate agents, an application of stable aqueous-aqueous emulsion
09/14/2005EP1572315A1 Apparatus and method for the isolation of produced particles as a suspension in a non-supercritical fluid
09/14/2005EP1572243A1 Induction of tolerance through oral administration of a therapeutic agent coupled to a transporting agent
09/14/2005EP1572241A1 Oral pharmaceutical compositions comprising cyclosporin
09/14/2005EP1572240A1 Compositions, methods, and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors
09/14/2005EP1572238A1 Agent with a retarded release of substances
09/14/2005EP1572230A1 Placental alkaline phosphatase to control diabetes
09/14/2005EP1572218A2 Ester combination local anesthetic
09/14/2005EP1572217A1 Combination medicament
09/14/2005EP1572216A1 Steroid compositions for intraocular use
09/14/2005EP1572206A2 Compositions of non-steroidal anti-inflammatory drugs decongestants and anti-histamines
09/14/2005EP1572201A1 Pharmaceutical compositions of sertaconazole for vaginal use
09/14/2005EP1572194A1 Anti-cancer composition comprising dmxaa or related compound
09/14/2005EP1572192A1 Controlled release preparations comprising tramadol and topiramate
09/14/2005EP1572190A1 Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
09/14/2005EP1572176A2 Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid
09/14/2005EP1572167A1 Transdermal buprenorphine dosage regimen for analgesia
09/14/2005EP1572166A1 Dermal delivery of a water-soluble selective cyclooxygenase-2 inhibitor, e.g. parecoxib, valdecoxib and benzopyran derivatives
09/14/2005EP1572165A1 New film coating
09/14/2005EP1572164A2 Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
09/14/2005EP1572163A1 Controlled-release of an active substance into a high fat environment
09/14/2005EP1572162A1 Method for producing coated pharmaceuticals and food supplements with concentration gradients in the coating thereof
09/14/2005EP1572161A1 Method for producing pharmaceuticals or food supplements comprising pigmented polymer coatings
09/14/2005EP1572160A2 Process for manufacturing sustained release microbeads containing venlafaxine hci
09/14/2005EP1572159A1 Stable topiramate formulations
09/14/2005EP1572158A1 A new oral immediated release dosage form
09/14/2005EP1572157A1 Formulation for fast dissolution of lipophilic compounds
09/14/2005EP1572156A1 Process for preparing combination pharmaceutical formulations using supercritical fluids
09/14/2005EP1572155A1 Quaternary compounds comprising propolis as the active substance
09/14/2005EP1572154A2 Medical devices employing novel polymers
09/14/2005EP1572153A1 Preparation of sterile aqueous suspensions comprising micronised crystalline active ingredients for inhalation
09/14/2005EP1572152A2 Liposomal analgesic formulation and use
09/14/2005EP1572151A1 Liquid dosage forms of proton pump inhibitors
09/14/2005EP1572150A1 Medicinal compositions comprising a core and a film based on modified cellulose derivatives
09/14/2005EP1572124A2 Hcv e1e2 vaccine compositions
09/14/2005EP1572122A2 Method of preventing infections from bioterrorism agents with immunostimulatory cpg oligonucleotides
09/14/2005EP1572093A2 Improved treatment of cancer with glutamine
09/14/2005EP1572074A2 Stabilized synthetic immunogen delivery system
09/14/2005EP1572067A2 Conjugates and compositions for cellular delivery
09/14/2005EP1571906A2 Powdery active ingredient formulations
09/14/2005EP1515698A4 Liposomes containing biologically active compounds
09/14/2005EP1498142A4 Polyfunctional biocompatible hydrogel and method for the production thereof
09/14/2005EP1460998A4 Extended release pharmaceutical tablet of metformin
09/14/2005EP1438060A4 Prevention and treatment of restenosis by local administration of drug
09/14/2005EP1383537A4 Novel chocolate composition as delivery system for nutrients and medications
1 ... 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 ... 2991